| 000 | 01903 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513031903.0 | ||
| 264 | 0 | _c19951004 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0021-9738 | ||
| 024 | 7 |
_a10.1172/JCI118184 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiorgino, F | |
| 245 | 0 | 0 |
_aDexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cSep 1995 |
||
| 300 |
_a1473-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDNA _xbiosynthesis |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aInsulin Receptor Substrate Proteins |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xbiosynthesis |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor II _xbiosynthesis |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xcytology |
| 650 | 0 | 4 | _aPhosphatidylinositol 3-Kinases |
| 650 | 0 | 4 |
_aPhosphoproteins _xbiosynthesis |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPhosphotransferases (Alcohol Group Acceptor) _xbiosynthesis |
| 650 | 0 | 4 | _aPhosphotyrosine |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-fos _xbiosynthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, IGF Type 1 _xbiosynthesis |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTyrosine _xanalogs & derivatives |
| 700 | 1 | _aSmith, R J | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 96 _gno. 3 _gp. 1473-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI118184 _zAvailable from publisher's website |
| 999 |
_c7544266 _d7544266 |
||